Yanli Shen

Sep 5, 2024 | dovepress.com | Bo Yu |Yanli Shen |Bing Xu |Yiyi Zhan

Introduction Lung cancer is a severe malignant tumor and remains one of the leading causes of cancer-related deaths globally.1 The predominant type of lung cancer is non-small cell lung cancer (NSCLC), constituting approximately 85% of all cases. NSCLC is further categorized into three main subtypes: large cell carcinoma (15%), lung squamous cell carcinoma (LUSC, 30%), and lung adenocarcinoma (LUAD, 40%).2 Treatment and prognosis for LUAD and LUSC vary depending on the subtype.